会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
    • 用于检测间变性大细胞淋巴瘤信号通路中蛋白质磷酸化的试剂
    • US07973134B2
    • 2011-07-05
    • US11503096
    • 2006-08-11
    • Albrecht MoritzKimberly LeeJohn RushRoberto Polakiewicz
    • Albrecht MoritzKimberly LeeJohn RushRoberto Polakiewicz
    • C07K16/00C07K16/18
    • G01N33/6842C07K16/44
    • The invention discloses 211 novel phosphorylation sites identified in signal transduction proteins and pathways underlying Anaplastic Large Cell Lymphoma (ALCL) involving the ALK-NPM translocation/fusion, and provides phosphorylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these phosphorylated sites/proteins, as well as methods of using the reagents for such purpose. Among the phosphorylation sites identified are sites occurring in the following protein types: Protein Kinases (including Receptor Tyrosine Kinases), Adaptor/Scaffold Proteins, Cellular Metabolism or Miscellaneous Enzymes, Oxidoreductases, Transcription Factors, Cytoskeletal Proteins, Translation Initiation Complexes, RNA Binding Proteins, Proteases, Acetyltransferases, G protein regulators/GTPases, Helicases, Apoptosis/Cell Cycle Regulation proteins, and Hydrolases.
    • 本发明公开了在信号转导蛋白中鉴定的211个新的磷酸化位点和涉及ALK-NPM易位/融合的间变性大细胞淋巴瘤(ALCL)的途径,并且为磷酸化位点特异性抗体和重同位素标记的肽(AQUA肽)提供了 这些磷酸化位点/蛋白质的选择性检测和定量,以及使用试剂用于此目的的方法。 鉴定的磷酸化位点是以下蛋白质类型发生的位点:蛋白激酶(包括受体酪氨酸激酶),适配器/支架蛋白,细胞代谢或其他酶,氧化还原酶,转录因子,细胞骨架蛋白,翻译起始复合物,RNA结合蛋白, 蛋白酶,乙酰转移酶,G蛋白调节剂/ GTP酶,Helicases,细胞凋亡/细胞周期调节蛋白和水解酶。
    • 9. 发明申请
    • Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
    • 用于检测T细胞受体信号通路中蛋白质磷酸化的试剂
    • US20070059845A1
    • 2007-03-15
    • US11503336
    • 2006-08-11
    • Albrecht MoritzKimberly LeeJohn RushRoberto Polakiewicz
    • Albrecht MoritzKimberly LeeJohn RushRoberto Polakiewicz
    • G01N33/543
    • G01N33/6872C12Q1/25C12Q1/485G01N33/6842
    • The invention discloses 95 novel phosphorylation sites identified in signal transduction proteins and pathways downstream of the T-cell receptor, and provides phosphorylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these phosphorylated sites/proteins, as well as methods of using the reagents for such purpose. Among the phosphorylation sites identified are sites occurring in the following protein types: Actin Binding proteins, Adaptor/Scaffold proteins, Adhesion proteins, Calcium-binding proteins, Cell Cycle Regulation or Channel proteins, Chaperones, Cofactor proteins, Cytoskeletal proteins, DNA Binding proteins, G protein or GTPase Activating proteins, Ligases, Lipid Kinases and Binding proteins, Oxidoreductases, Protein Kinases, Protein Phosphatases, Receptor proteins, RNA Binding proteins, Transcription Factor/Initiation Complex proteins, Transcription Coactivator/Corepressor proteins, Translation Initiation Complex proteins, Ubitquitin Conjugating System proteins, and Vesicle proteins.
    • 本发明公开了在T细胞受体下游的信号转导蛋白和途径中鉴定的95个新的磷酸化位点,并提供磷酸化位点特异性抗体和重同位素标记肽(AQUA肽),用于选择性检测和定量这些磷酸化位点/ 蛋白质,以及使用试剂用于此目的的方法。 鉴定的磷酸化位点是发生在以下蛋白质类型中的位点:肌动蛋白结合蛋白,衔接/支架蛋白,粘附蛋白,钙结合蛋白,细胞周期调节或通道蛋白,伴侣蛋白,辅因子蛋白,细胞骨架蛋白,DNA结合蛋白, G蛋白或GTPase激活蛋白,连接酶,脂质激酶和结合蛋白,氧化还原酶,蛋白激酶,蛋白磷酸酶,受体蛋白,RNA结合蛋白,转录因子/起始复合蛋白​​,转录共激活因子/ Corepressor蛋白,翻译起始复合蛋白​​,Ubitquitin缀合 系统蛋白和囊泡蛋白。